No Data
No Data
Nikkei Average Contribution Ranking (Pre-Close) ~ The Nikkei Average continued to decline, with Fast Retailing lowering it by about 113 yen for one stock.
As of the close on the 21st, the number of rising and falling stocks in the Nikkei average was 88 up, 133 down, and 4 unchanged. The Nikkei average continued to decline, finishing the morning trade at 38,033.22 yen, down 319.12 yen (-0.83%) from the previous day (with an estimated volume of 0.8 billion 30 million shares). On the 20th, the U.S. stock market was mixed. The dow inc was up 139.53 points at 43,408.47 dollars, while the nasdaq ended down 21.33 points at 18,966.14. Ukraine.
The Nikkei Average fell, with Tokyo Electric pushing down about 23 yen per share as one stock.
The number of rising stocks of Nikkei average constituent stocks at the closing of 20 days ago was 68 stocks rising, 156 stocks falling, and 1 stock unchanged. The Nikkei average fell for the first time in 7 days, closing the morning session at 32,870.00 yen (volume approximately 0.658.53 million shares) down 69.18 yen. The Nikkei average fell, closing the morning session at 38,242.35 yen (volume approximately 0.830 million shares) down 172.08 yen (-0.45%) from the previous day. The US stock market on the 19th was mixed. The Dow Jones Industrial Average was 120 points.
Express News | Otsuka Provides Update on Sibeprenlimab, an Investigational Monoclonal Antibody for Treatment of Iga Nephropathy in Adults
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○ List of stocks transitioning to sell mode Market Code Company Name Closing Price SAR Main Board <1662> Petroleum Resources 1097 1175 <1663> K&O Energy 28753160 <1721> Comsys HD 31263299 <1861> Kumagai Gumi 34203610 <1879> Shin-Nihon Construction 15071590 <187A> Samty HD 32953300 <1963> JGC HD 13221412 <197
Otsuka Holdings Expands Into North American IV Market
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
No Data
No Data